Late-Onset Ankylosing Spondylitis and Spondylarthritis: An Update on Clinical Manifestations, Differential Diagnosis and Pharmacological Therapies

By Toussirot Éric  

Drugs & Aging, Vol. 27, Iss. 7, 2010-07 ,pp. : 523-531

Adis International

Access to resources Recommend Favorite

Pharmacological Treatment of Ankylosing Spondylitis: A Systematic Review

By Boulos Pauline  

Drugs, Vol. 65, Iss. 15, 2005-01 ,pp. : 2111-2127

Adis International

Access to resources Recommend Favorite

Bisphosphonates as anti-inflammatory agents in ankylosing spondylitis and spondylarthropathies

By Toussirot Éric   Wendling Daniel  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 1, 2005-01 ,pp. : 35-43

Informa Healthcare

Access to resources Recommend Favorite

Tumour necrosis factor-α inhibitors have a growing role in managing late-onset ankylosing spondylitis and spondylarthritis

By  

Drugs & Therapy Perspectives, Vol. 27, Iss. 2, 2011-02 ,pp. : 13-16

Adis International

Access to resources Recommend Favorite

Neutrophil–Lymphocyte Ratio Connected to Treatment Options and Inflammation Markers of Ankylosing Spondylitis

By  

Journal Of Clinical Laboratory Analysis (Electronic), Vol. 29, Iss. 4, 2015-07 ,pp. : 294-298

John Wiley & Sons Inc

Access to resources Recommend Favorite